- Narrative Type
| - Narrative Text
|
Additional Text | As announced by Healthway Medical Corporation Limited (the "Company") on 12 October 2023, the percentage of the total number of issued shares of the Company held in the public hands has fallen below 10%. |
Additional Text | As the Exit Offer has closed at 5.30 p.m. (SGT) on 26 October 2023, in connection with the Company's voluntary delisting form the Catalist Board of the SGX-ST, the Company has accordingly requested the SGX-ST to suspend the trading of the Company's shares with effect from 9.00 a.m. (SGT) on 27 October 2023. |
Additional Text | This announcement has been reviewed by the Company's sponsor, PrimePartners Corporate Finance Pte. Ltd. (the "Sponsor"). |
Additional Text | It has not been examined or approved by the Singapore Exchange Securities Trading Limited (the "Exchange") and the Exchange assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement. |
Additional Text | The contact person for the Sponsor is Ms. Foo Jien Jieng, 16 Collyer Quay, #10-00 Collyer Quay Centre, Singapore 049318, sponsorship@ppcf.com.sg. |